« Hedge funds are interested in raw material - The volume of houses construction in the USA has fallen to 10,2 % »
The net profit Johnson&Johnson has decreased up to $8,2 billion
17 October 2007During nine months of current year Johnson&Johnson’s (JNJ) net profit has decreased on 7,7 % and has made 8,2 billion dollars (2,81 dollars per share). Such data are resulted in the financial report of the company published on October, 16th.
For the similar period of 2006 net profit of the company made 8,89 billion dollars (2,99 dollars per share).
JNJ’s quarter net profit has fallen on 7,7 %. during the III quarter of 2007 it has made 2,55 billion dollars, i.e. 0,88 dollars per share, in comparison with 2,76 billion dollars for the similar period in 2006 (0,94 dollars per share).
During accounting period JNJ’s sales volume has, on the contrary, increased and has made 45,14 billion dollars against 39,64 billion dollars in January-September of the last year. At the same time in III quarter of this year sales volume has grown on 12,7 % and has made 14,97 billion dollars against 13,29 billion, received in 2007.
Johnson&Johnson specializes on manufacture and promotion of the goods in sphere of public health services. The company connects the received financial parameters with expenses of re-structuring program.
Let’s remind, that in April 2007, the company has finished merge with Conor Medsystems - the American manufacturer of cardiovascular preparations. It has reduced JNJ’s budget on 807 million dollars.
Meanwhile the company connects growth of incomes with effective activity of pharmaceutical division, and also with favorable changes of exchange rates, in as a result of which JNJ’s sales have essentially grown as in home and abroad market.
- In I half-year net profit of HSBC has decreased on 29 %
- Net profit of Société Générale has decreased on 81,9 %
- Credit Suisse’s net profit has grown up to 4,31 billion euro
- Х5 has paid off for aggressive development
Leave a reply
You must be logged in to post a comment.
